(Q45403737)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Oseltamivir distributes to influenza virus replication sites in the middle ear and sinuses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Michael Kurowski

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Hugh Wiltshire

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Joanne Barrett

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516690%20AND%20SRC:MED&resulttype=core&format=json

Clinical Drug Investigation

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

49-53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516690%20AND%20SRC:MED&resulttype=core&format=json

Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine.

30 December 2019

cites work

1 reference

12 December 2020

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

1 reference

12 December 2020

Prevalence of Various Respiratory Viruses in the Middle Ear during Acute Otitis Media

1 reference

12 December 2020

Oral oseltamivir treatment of influenza in children.

1 reference

12 December 2020

Penetration of GS4071, a novel influenza neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug GS4104.

1 reference

12 December 2020

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

1 reference

12 December 2020

Effect of Streptococcus pneumoniae and influenza A virus on middle ear antimicrobial pharmacokinetics in experimental otitis media

1 reference

12 December 2020

Influenza A virus infection of human middle ear cells in vitro

1 reference

12 December 2020

Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza

1 reference

12 December 2020

Impact of epidemic type A influenza in a defined adult population

1 reference

12 December 2020

Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom

1 reference

12 December 2020

Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection

1 reference

12 December 2020

Influence of pH on the antimicrobial activity of clarithromycin and 14-hydroxyclarithromycin against Haemophilus influenzae using an in vitro pharmacodynamic model

1 reference

12 December 2020

Respiratory mucus pH in tracheostomized intensive care unit patients: Effects of colonization and pneumonia

1 reference

12 December 2020

In-vitro and in-vivo efficacy of influenza neuraminidase inhibitors.

1 reference

12 December 2020

Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802.

1 reference

12 December 2020